Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 22 Sept 2026 for ALNYLAM PHARMACEUTICALS, INC.. Read the official filing
Filing timeline
BuySaleYvonne Greenstreet
Insider track record
Disclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Yvonne Greenstreet: trading record in brief
Yvonne Greenstreet (chief executive) discloses dealings in 2 companies, chiefly Alnylam Pharmaceuticals, Inc. and Pacira BioSciences, Inc. In total, 61 filings cover trades dated from 9 June 2021 to 19 September 2026.
Every open-market trade on record is a sale: 29 sales worth €21.2M. Besides market trades, the filings include 18 share grants and 12 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 22 September 2026, reports a share grant in Alnylam Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Yvonne Greenstreet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations61 total
107 shares0Common StockSEC:0001178670-26-000065:0
135 shares@ US$319.030.1% of flowCommon StockSEC:0001735276-26-000062:0
13,844 shares0Common StockSEC:0001735276-26-000048:0
5,921 shares0Common StockSEC:0001735276-26-000041:0
6,958 shares@ US$310.08085.6% of flowCommon StockSEC:0001735276-26-000028:1
14,209 shares0Common StockSEC:0001735276-26-000028:0
19,003 shares0Common StockSEC:0001735276-26-000014:0
839 shares@ US$119.130.3% of flowCommon StockSEC:0001735276-25-000125:0
650 shares@ US$42.220.1% of flowCommon StockSEC:0001735276-25-000120:0
3,860 shares0Common StockSEC:0001735276-25-000116:0
195 shares@ US$450.920.2% of flowCommon StockSEC:0001735276-25-000089:3
514 shares@ US$451.990.6% of flowCommon StockSEC:0001735276-25-000089:4
1,646 shares@ US$452.962.0% of flowCommon StockSEC:0001735276-25-000089:5
2,716 shares@ US$454.043.3% of flowCommon StockSEC:0001735276-25-000089:6
1,204 shares@ US$454.841.4% of flowCommon StockSEC:0001735276-25-000089:7
60 shares@ US$455.820.1% of flowCommon StockSEC:0001735276-25-000089:8
14,252 shares0Common StockSEC:0001735276-25-000089:0
194 shares@ US$447.980.2% of flowCommon StockSEC:0001735276-25-000089:1
450 shares@ US$449.920.5% of flowCommon StockSEC:0001735276-25-000089:2
12,081 shares@ US$119.133.9% of flowCommon StockSEC:0001735276-25-000075:0
19,559 shares@ US$118.056.3% of flowCommon StockSEC:0001735276-25-000075:1
25,469 shares@ US$304.0021.0% of flowCommon StockSEC:0001735276-25-000075:2
6,171 shares@ US$306.005.1% of flowCommon StockSEC:0001735276-25-000075:3
12,080 shares@ US$119.133.9% of flowCommon StockSEC:0001735276-25-000075:4
7,217 shares@ US$118.052.3% of flowCommon StockSEC:0001735276-25-000075:5
25 of 61 declarations
